WESTDEUTSCHES PROTONENTHERAPIEZENTRUM ESSEN (WPE) GGMBH

Their core work

WPE is a dedicated proton therapy center in Essen, Germany, treating cancer patients — particularly children — with precision proton beam radiation. Their EU research role is to contribute clinical expertise, patient cohort access, and hands-on proton therapy infrastructure to multi-site radiation research networks. In H2020 projects they have worked on two distinct fronts: quantifying the long-term health risks of radiation exposure in paediatric cardiac and cancer patients, and investigating the biological mechanisms that determine how tumors respond or resist therapeutic radiation. This makes them a rare bridge between an operating clinical facility and translational radiation research.

What they specialise in

How they've shifted over time

Both of WPE's H2020 projects began in 2019, so there is no genuine temporal shift to trace — the early/recent keyword split reflects two parallel research themes rather than a change in direction over the years. Their HARMONIC work centers on population-level radiation safety, dose tracking, and epidemiology, while THERADNET covers the cellular and molecular biology of therapeutic radiation. Taken together, the picture that emerges is an organization that entered EU-funded research simultaneously from two complementary angles: the safety of radiation from the patient and public health perspective, and the biology of radiation from the therapeutic and mechanistic side.

WPE appears to be building toward an integrated research identity that couples clinical dosimetry and patient safety with molecular radiobiology — a combination that positions them well for future projects on personalized radiation therapy and immunoradiotherapy.

How they like to work

WPE has participated in all H2020 projects as a partner, never taking on the coordinator role — consistent with a specialized clinical center that contributes a defined capability (proton therapy infrastructure and patient access) rather than managing large consortia. Despite only two projects, they have accumulated 29 unique consortium partners across 13 countries, which signals that both networks they joined were large, multi-institutional affairs. Working with WPE likely means gaining access to a focused clinical resource: proton beam facility, paediatric oncology patient cohorts, and radiation biology expertise, rather than a broad project management partner.

WPE has built a surprisingly wide network for an organization with only two projects — 29 partners across 13 countries, reflecting participation in large pan-European research consortia. Their geographic footprint spans well beyond Germany, suggesting strong integration into the European radiation oncology and medical physics research community.

What sets them apart

WPE is one of very few dedicated proton therapy centers in Germany that is also actively engaged in EU-funded research, making them a rare combination of operational clinical facility and scientific collaborator — most research institutes in this space lack a functioning treatment center, and most treatment centers do not participate in research networks. Their specific focus on paediatric proton therapy adds further differentiation: the intersection of children's oncology, radiation safety, and proton beam technology is a narrow but high-value niche. For a consortium building a project that requires both clinical validation capacity and mechanistic radiobiology expertise, WPE offers both under one roof.

Highlights from their portfolio

• HARMONIC
  The largest-budget project in WPE's portfolio (€388,788), addressing a significant public health question — long-term radiation risks in children undergoing cardiac procedures or cancer radiotherapy — with a five-year follow-up running to 2024.
• THERADNET
  An MSCA-ITN training network, showing WPE's role in mentoring the next generation of therapeutic radiation researchers across radiobiology, DNA damage response, and tumor resistance — a signal of recognized expertise within the European radiation oncology training ecosystem.